secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eloxx Pharmaceuticals, Inc. (ELOX)
CIK:        0001035354
Form:       8-K
Filed at:   2021-07-16T23:59:59+00:00
Accession:  0001104659-21-093086
Event type: leadership
Sentiment:  negative
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Eloxx Pharmaceuticals loses Principal Accounting Officer Gary Rakers effective July 30, 2021
--------------------------------------------------------------------------------

- Gary Rakers resigns as Executive Director, Finance & Accounting, Corporate Controller and Treasurer (Principal Accounting Officer).
- Resignation effective July 30, 2021, to pursue another business opportunity.
- Rakers had been with the company since January 2020.
- Company has not yet named a successor; intends to appoint one as soon as possible.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035354/000110465921093086/0001104659-21-093086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035354/000110465921093086/tm2122445d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-093086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer